Emerging Approaches for Cardiovascular Stem Cell Imaging

Current Cardiovascular Imaging Reports

Volumn 4, Issue 1, 2011, Pages 32-40

  Kedziorek, Dorota A ^a   Kraitchman, Dara L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Bioluminescence; Heart diseases; Magnetic resonance imaging; Optical imaging; Positron emission tomography; Single photon emission computed tomography; Stem cell transplantation and imaging

Indexed keywords

EID: 84873052231     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-010-9057-1     Document Type: Review

References (50)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al., Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121(7): 948-954.
2. Quevedo HC, Hatzistergos KE, Oskouei BN, et al., Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 2009, 106(33): 14022-7.
3. Nelson TJ, Martinez-Fernandez A, Yamada S, et al., Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009, 120(5): 408-16.
4. Rosenzweig A, Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006, 355(12): 1274-7.
5. Assmus B, Honold J, Schachinger V, et al., Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355(12): 1222-32.
6. • Menasche P, Cardiac cell therapy: Lessons from clinical trials. J Mol Cell Cardiol. 2010, epub 2010/07/06. This is a detailed overview of clinical trials with stem cell therapies for cardiac diseases.
7. Wu JC, Abraham MR, and Kraitchman DL, Current perspectives on imaging cardiac stem cell therapy. J Nucl Med, 51 Suppl 1: 128S-136S.
8. Frangioni JV and Hajjar RJ, In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 2004, 110(21): 3378-83.
9. Kedziorek DA and Kraitchman DL, Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. Methods Mol Biol 2010, 660: 171-83.
10. Walczak P, Kedziorek DA, Gilad AA, et al., Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Med 2007, 58(2): 261-9.
11. Liu J, Cheng EC, Long Jr RC, et al., Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods 2009.
12. • Chen IY, Greve JM, Gheysens O, et al., Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol 2009, 11(3): 178-87. This preclinical study suggests that bioluminescence is a more accurate technique for transplanted cell survival estimation than MRI of iron oxide-labeled cells.
13. • Gyongyosi M, Blanco J, Marian T, et al., Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 2008, 1(2): 94-103. This is the first large animal preclinical study with reporter gene imaging using clinical scanners demonstrating potential for clinical translation.
14. Gilad AA, McMahon MT, Walczak P, et al., Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 2007, 25(2): 217-219.
15. Pawelczyk E and Frank JA, Transferrin receptor expression in iron oxide-labeled mesenchymal stem cells. Radiology 2008, 247(3): 913; author reply 914-5.
16. Bulte JW and Kraitchman DL, Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004, 17(7): 484-499.
17. • Adler ED, Bystrup A, Briley-Saebo KC, et al., In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium. JACC Cardiovasc Imaging 2009, 2(9): 1114-22. This is an interesting study employing gadolinium-based contrast agent for murine embryonic stem cell-derived tracking of post-intramyocardial transplantation.
18. Budde MD and Frank JA, Magnetic tagging of therapeutic cells for MRI. J Nucl Med 2009, 50(2): 171-4.
19. Brekke C, Morgan SC, Lowe AS, et al., The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed 2007, 20(2): 77-89.
20. Anderson SA, Lee KK, and Frank JA, Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol 2006, 41(3): 332-8.
21. Kraitchman DL and Bulte JW, In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods. Arterioscler Thromb Vasc Biol 2009, 29(7): 1025-30.
22. Cunningham CH, Arai T, Yang PC, et al., Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005, 53(5): 999-1005.
23. Mani V, Adler E, Briley-Saebo KC, et al., Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med 2008, 60(1): 73-81.
24. Stuber M, Gilson WD, Schär M, et al., Positive contrast visualization of iron oxide-labeled stem cells using inversion recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007, 58: 1072-1077.
25. Dahnke H, Liu W, Herzka D, et al., Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn Reson Med 2008, 60(3): 595-603.
26. • Zhou R, Idiyatullin D, Moeller S, et al., SWIFT detection of SPIO-labeled stem cells grafted in the myocardium. Magn Reson Med 2010, 63(5): 1154-61. This is a report from a study using a novel positive-contrast method to detect murine embryonic stem cells labeled with iron oxide particles and injected into the myocardium.
27. Frank JA, Miller BR, Arbab AS, et al., Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003, 228(2): 480-7.
28. Kostura L, Kraitchman DL, Mackay AM, et al., Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004, 17(7): 513-7.
29. Kedziorek DA, Muja N, Walczak P, et al., Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med 2010, 63(4): 1031-43.
30. de Silva R, Gutierrez LF, Raval AN, et al., X-Ray Fused with Magnetic Resonance Imaging (XFM) to target endomyocardial injections. Validation in a swine model of myocardial infarction. Circulation 2006, 114(22): 2342-2350.
31. Li Z, Suzuki Y, Huang M, et al., Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008, 26(4): 864-73.
32. Ebert SN, Taylor DG, Nguyen HL, et al., Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells 2007, 25(11): 2936-44.
33. Partlow KC, Chen J, Brant JA, et al., 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb J 2007, 21(8): 1647-54.
34. Graham JJ, Foltz WD, Vaags AK, et al., Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI. Am J Physiol Heart Circ Physiol 2010, 299(1): H125-33.
35. Psaltis PJ, Zannettino AC, Gronthos S, and Worthley SG, Intramyocardial navigation and mapping for stem cell delivery. J Cardiovasc Transl Res 2010, 3(2): 135-46.
36. Jameel MN, Li Q, Mansoor A, et al., Long-term functional improvement and gene expression changes after bone marrow-derived multipotent progenitor cell transplantation in myocardial infarction. Am J Physiol Heart Circ Physiol 2010, 298(5): H1348-56.
37. • Rodriguez-Porcel M, In vivo imaging and monitoring of transplanted stem cells: clinical applications. Curr Cardiol Rep 2010, 12(1): 51-8. This is an excellent review of stem cell therapies for cardiovascular disease imaging.
38. Terrovitis J, Lautamaki R, Bonios M, et al., Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 2009, 54(17): 1619-26.
39. Higuchi T, Anton M, Saraste A, et al., Reporter gene PET for monitoring survival of transplanted endothelial progenitor cells in the rat heart after pretreatment with VEGF and atorvastatin. J Nucl Med 2009, 50(11): 1881-6.
40. Willmann JK, Paulmurugan R, Rodriguez-Porcel M, et al., Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology 2009, 252(1): 117-27.
41. Terrovitis J, Kwok KF, Lautamaki R, et al., Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol 2008, 52(20): 1652-60.
42. van der Bogt KE, Sheikh AY, Schrepfer S, et al., Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 2008, 118(14 Suppl): S121-9.
43. Swijnenburg RJ, Govaert JA, van der Bogt KE, et al., Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction. Circ Cardiovasc Imaging 2010, 3(1): 77-85.
44. Gruber PJ, Li Z, Li H, et al., In vivo imaging of MLC2v-luciferase, a cardiac-specific reporter gene expression in mice. Acad Radiol 2004, 11(9): 1022-8.
45. • Sutton EJ, Henning TD, Pichler BJ, et al., Cell tracking with optical imaging. Eur Radiol 2008, 18(10): 2021-32. This is a comprehensive overview of emerging applications for optical imaging techniques for in vivo monitoring of new stem cell-based therapies.
46. • Ly HQ, Hoshino K, Pomerantseva I, et al., In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. Eur Heart J 2009, 30(23): 2861-8. This remarkable study used quantum dots and fluorescence to track stem cells post-intracoronary delivery.
47. Rosen AB, Kelly DJ, Schuldt AJ, et al., Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007, 25(8): 2128-38.
48. • Kuliszewski MA, Fujii H, Liao C, et al., Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles. Cardiovasc Res 2009, 83(4): 653-62. This is an interesting study employing ultrasound to track the vascular engraftment of endothelial progenitor cells.
49. Barnett BP, Arepally A, Karmarkar PV, et al., Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med 2007, 13(8): 986-91.
50. • Barnett BP, Kraitchman DL, Lauzon C, et al., Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol Pharm 2006, 3(5): 531-8. This is the first X-ray visible stem cell therapy comprised of clinical components in small animals.